Medical treatment of primary sclerosing cholangitis with ursodeoxycholic acid

被引:4
作者
Chapman, RW [1 ]
机构
[1] John Radcliffe Hosp, Oxford OX3 9DU, England
关键词
BILE-ACIDS; LIVER; URSODIOL; DISEASE;
D O I
10.1016/S1590-8658(03)00072-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:306 / 308
页数:3
相关论文
共 16 条
[1]
URSODEOXYCHOLIC ACID FOR TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS - A PLACEBO-CONTROLLED TRIAL [J].
BEUERS, U ;
SPENGLER, U ;
KRUIS, W ;
AYDEMIR, U ;
WIEBECKE, B ;
HELDWEIN, W ;
WEINZIERL, M ;
PAPE, GR ;
SAUERBRUCH, T ;
PAUMGARTNER, G .
HEPATOLOGY, 1992, 16 (03) :707-714
[2]
Liver transplantation for primary sclerosing cholangitis [J].
Gow, PJ ;
Chapman, RW .
LIVER, 2000, 20 (02) :97-103
[3]
Harnois DM, 2001, AM J GASTROENTEROL, V96, P1558
[4]
Effects of ursodeoxycholic acid and chenodeoxycholic acid on major histocompatibility complex class I gene expression [J].
Hirano, F ;
Tanaka, H ;
Makino, Y ;
Okamoto, K ;
Makino, I .
JOURNAL OF GASTROENTEROLOGY, 1996, 31 (01) :55-60
[5]
Ursodiol for primary sclerosing cholangitis [J].
Lindor, KD .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (10) :691-695
[6]
Different bile acids exhibit distinct biological effects: The tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation [J].
Martinez, JD ;
Stratagoules, ED ;
LaRue, JM ;
Powell, AA ;
Gause, PR ;
Craven, MT ;
Payne, CM ;
Powell, MB ;
Gerner, EW ;
Earnest, DL .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1998, 31 (02) :111-118
[7]
MITCHELL SA, 2001, GASTROENTEROLOGY, P122
[8]
URSODEOXYCHOLIC ACID FOR THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS - A 30-MONTH PILOT-STUDY [J].
OBRIEN, CB ;
SENIOR, JR ;
ARORAMIRCHANDANI, R ;
BATTA, AK ;
SALEN, G .
HEPATOLOGY, 1991, 14 (05) :838-847
[9]
Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey [J].
Okolicsanyi, L ;
Groppo, M ;
Floreani, A ;
Morselli-Labate, AM ;
Rusticali, AG ;
Battocchia, A ;
Colombo, M ;
Galatola, G ;
Gasbarrini, G ;
Podda, M ;
Ricci, G ;
Rosina, F ;
Zuin, M .
DIGESTIVE AND LIVER DISEASE, 2003, 35 (05) :325-331
[10]
Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited [J].
Paumgartner, G ;
Beuers, U .
HEPATOLOGY, 2002, 36 (03) :525-531